GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2026 Earnings Call Highlights: Navigating ...

GSK Licenses Shigella Vaccine to Bharat Biotech

Patents and economies of scale support Pfizer's wide moat

Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue?

Glaxo (GSK) Up 3.2% Since Last Earnings Report: Can It Continue?